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Mitochondrial outer membrane permeabilization (MOMP)
constitutes one of the major checkpoint(s) of apoptotic
and necrotic cell death. Recently, the permeabilization of
yet another organelle, the lysosome, has been shown to
initiate a cell death pathway, in speciﬁc circumstances.
Lysosomal membrane permeabilization (LMP) causes the
release of cathepsins and other hydrolases from the
lysosomal lumen to the cytosol. LMP is induced by a
plethora of distinct stimuli including reactive oxygen
species, lysosomotropic compounds with detergent activ-
ity, as well as some endogenous cell death effectors such as
Bax. LMP is a potentially lethal event because the ectopic
presence of lysosomal proteases in the cytosol causes
digestion of vital proteins and the activation of additional
hydrolases including caspases. This latter process is
usually mediated indirectly, through a cascade in
which LMP causes the proteolytic activation of Bid
(which is cleaved by the two lysosomal cathepsins B and
D), which then induces MOMP, resulting in cytochrome c
release and apoptosome-dependent caspase activation.
However, massive LMP often results in cell death without
caspase activation; this cell death may adopt a subapop-
totic or necrotic appearance. The regulation of LMP is
perturbed in cancer cells, suggesting that speciﬁc
strategies for LMP induction might lead to novel
therapeutic avenues.
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Introduction
Physiological and pathological cell death have been
classiﬁed according to morphological criteria into at
least three categories: type I cell death or apoptosis; type
II cell death or autophagic cell death; and type III cell
death or necrosis (Clarke, 1990; Kroemer et al., 2005;
Galluzzi et al., 2007). Apoptosis or type I programmed
cell death is characterized by cell rounding and nuclear
condensation. The cell diminishes in size, the plasma
membrane starts to bleb and the cell ﬁnally fragments
into apoptotic bodies that are engulfed by neighboring
cells where they are degraded within phagolysosomes.
This type of cell death has been extensively studied and
(some of) the molecular pathways have now been
elucidated. Among these, mitochondrial outer mem-
brane permeabilization (MOMP) and caspase activation
have prominent functions: the former determines the
point of no return of the lethal process; the latter
orchestrates the morphological and biochemical changes
that characterize apoptosis (Taylor et al., 2008; Youle
and Strasser, 2008). MOMP is regulated by the Bcl-2
family of proteins, which act as inducers or blockers of
the process. As a result of MOMP, proapoptotic
molecules such as cytochrome c are released into the
cytosol and contribute to the activation of caspases
(Kroemer et al., 2007; Taylor et al., 2008; Youle and
Strasser, 2008). Caspases are aspartic proteases that are
responsible for the degradation of hundreds of cyto-
plasmic and nuclear proteins in the apoptotic cell.
Caspases can be activated after MOMP or indepen-
dently of MOMP (Taylor et al., 2008). Other mitochon-
drial proteins such as the apoptosis-inducing factor
(AIF) are also released from the mitochondria during
apoptosis and activate caspase-independent cell death
pathways (Modjtahedi et al., 2006).
Autophagy is a lysosomal degradative pathway by
which cells degrade and recycle macromolecules and
organelles (Mizushima, 2007). As a result of the
discovery of the proteins responsible for this pheno-
menon—the autophagy (Atg) proteins—and the impli-
cation of autophagy in a plethora of pathological
situations, this process has received great attention
(Klionsky, 2007; Levine and Kroemer, 2008). Although
autophagy was initially described as a type of cellular
demise, it remains unclear whether autophagy represents
an independent mode of programmed cell death, a
backup mechanism of cell death when apoptosis is
inhibited or simply a stress response that is activated in
damaged cells (Maiuri et al., 2007). Indeed, one possible
explanation for the frequent presence of autophago-
somes in dying cells is that cells upregulate autophagy in
an attempt to eliminate toxic molecules or damaged
organelles and that cells die from apoptosis or necrosis
only once the autophagic system of defense has been
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overwhelmed. Necrosis has been deﬁned as a type of
cell death that lacks the features of apoptosis
and autophagy, and is often considered to be an
uncontrolled process. However, recent research suggests
that its occurrence and course might be regulated.
Following a signaling- or damage-induced lesion,
necrosis can include signs of controlled processes such
as mitochondrial dysfunction, enhanced generation of
reactive oxygen species, ATP depletion, proteolysis by
calpains and cathepsins, and early plasma membrane
rupture. In addition, the inhibition of speciﬁc proteins
involved in regulating apoptosis or autophagy can
change the morphological appearance of cell death to
necrosis (Festjens et al., 2006; Golstein and Kroemer,
2007).
Cell death can be triggered by toxic insults from the
extracellular or intracellular milieu. Thus, the damage of
nuclear DNA or the endoplasmic reticulum both induce
apoptotic cell death that is dependent on MOMP and
caspase activation (Ferri and Kroemer, 2001; Boya
et al., 2002). In addition, lysosomal damage can induce
MOMP-dependent cell death and lysosomal proteases
released into the cytosol have been implicated in
apoptotic cell death. In this review, we will focus on
recent discoveries that implicate lysosomal membrane
permeabilization (LMP) in cell death.
Lysosomes and LMP
Lysosomes are cytoplasmic membrane-enclosed orga-
nelles that contain hydrolytic enzymes and that control
the intracellular turnover of macromolecules (Luzio
et al., 2007). Lysosomes contain many different types
of hydrolytic enzymes including proteases, lipases,
nucleases, glycosidases, phospholipases, phosphatases
and sulfatases that usually exert their maximal enzy-
matic activity at low pH. The acidic milieu of lysosomes
(pHp5) is maintained by a vacuolar ATPase that
pumps protons from the cytosol into the lysosomal
lumen (Luzio et al., 2007). The lysosomal membrane is
protected from the acidic hydrolases by lysosome-
speciﬁc expression of membrane proteins such as
Lamp-1 and Lamp-2, which are heavily glysosylated
and hence resist digestion (Eskelinen, 2006). Several
degradation pathways converge at the level of lyso-
somes. This applies to the endocytotic degradation of
plasma membrane receptors and proteins from the
extracellular matrix, as well as the phagocytotic
degradation of bacteria and apoptotic cells. If the
material that is degraded derives from the cell itself,
the process of lysosome-dependent degradation is called
autophagy (Mizushima, 2007). During macroauto-
phagy, cytoplasmic components such as long-lived and
damaged proteins, as well as entire organelles, are
degraded and recycled to generate ATP as well as new
building blocks for anabolic processes (Levine and
Kroemer, 2008). Indeed, autophagy protects cells under
conditions of nutrient starvation and, in some circum-
stances of cellular stress, cells die by apoptosis when
autophagy is inhibited either pharmacologically or by
depletion of essential atg gene products (Boya et al.,
2005; Gonzalez-Polo et al., 2005).
The high content of hydrolytic enzymes in lysosomes
makes them potentially harmful to the cell. If the
lysosomal membrane is damaged, lysosomes release
their contents into the cytosol, setting off indiscriminate
degradation of cellular components. In addition, mas-
sive lysosomal breakdown may induce cytosolic acid-
iﬁcation, which in turn can induce cell death by necrosis.
This concept was ﬁrst appreciated by de Duve (1959),
the discoverer of lysosomes, who termed them ‘suicide
bags’. However, as we will discuss, partial and selective
LMP induces cell death by apoptosis. Under these
circumstances, proteases liberated from the lysosomal
lumen activate a controlled mode of cell death (for
earlier reviews see Guicciardi et al., 2004; Kroemer and
Jaattela, 2005; Tardy et al., 2006; Terman et al., 2006).
We will refer to this process as LMP.
Lysosomal proteases that have been implicated in cell
death are those cathepsins that remain active at neutral
pH, such as cathepsin B (CB), cathepsin D (CD) and
cathepsin L (CL). These proteases activate apoptotic
effectors such as mitochondria and/or caspases. In spite
of the extensive characterization of apoptosis mechan-
isms, the involvement of lysosomes in cell death has
been neglected for several reasons. First, at the level of
transmission electron microscopy, the ultrastructure of
lysosomes appears intact during apoptosis, even when
LMP can be detected by immunoﬂuorescence techni-
ques. Second, several pharmacological inhibitors of
apoptosis (caspase inhibitors) also block lysosomal
proteases when they are used at high concentrations
(Foghsgaard et al., 2001). Thus, the cytoprotective
effects of inhibitors such as Z-VAD-fmk may well
include hitherto neglected effects on lysosomal proteases
(Turk and Stoka, 2007).
‘Lysosomotropic agents’ accumulate within lyso-
somes. This term was coined by de Duve et al. (1974)
to describe weakly basic amines that attain concentra-
tions several 100-fold higher within the lysosomes than
in the cytosol. Lysosomotropic amines freely diffuse
across membranes in their uncharged form but become
trapped in their protonated (non-diffusible) form when
they are localized in acidic vesicles. In the 1980s, several
lysosomotropic compounds were synthesized that were
capable of lysing lysosomal membranes. Accumulation
of the protonated form above a certain threshold
concentration results in their acquisition of detergent-
like properties, which induce lethal lysosomal destabi-
lization. As a proof of principle for this concept,
lysosomotropic detergents cannot lyse red blood cells,
which do not possess lysosomes (Firestone et al., 1982;
Miller et al., 1983).
Lysosomal membrane permeabilization: its detection
The distinctive sign of LMP is the translocation of
soluble lysosomal components (including enzymes) from
the lysosomal lumen to the cytosol. Accordingly, LMP
can be measured by a variety of simple techniques.
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Immunoﬂuorescence techniques using antibodies
against cathepsins such as CB and CD reveal the
redistribution of these proteases from lysosomes to the
cytosol (Figure 1a). In healthy cells, CB- or CD-speciﬁc
immunostainings reveal cytoplasmic punctate structures
that are surrounded by lysosomal membrane proteins
such as Lamp-1 and Lamp-2. After LMP, the immuno-
ﬂuorescence detection of CB or CD reveals a diffuse
staining throughout the entire cell (Boya et al., 2003a).
The translocation of CB or CD from lysosomes to the
cytosol can also be detected by immunoblots of
subcellular fractions, typically cytosolic versus heavy
membrane fractions (which include mitochondria and
lysosomes) (Michallet et al., 2004). Cytosolic protease
activity can be measured using lysosome-impermeable
cathepsin substrates such as pepstatin BODIPY (Yin
et al., 2005). Alternatively, protease activities can be
monitored in cytosolic extracts with cathepsin-speciﬁc
substrates such as zFR-amino-triﬂuoromethylcoumarin
(Groth-Pedersen et al., 2007). Cytosolic cathepsin
translocation can also be visualized by transfecting cells
with fusion constructs encoding cathepsins that have
been coupled to ﬂuorescent proteins (Werneburg et al.,
2002, 2007; Broker et al., 2005). Furthermore, lysosomal
destabilization can be determined by pulse-chase
experiments, in particular by loading lysosomes with
CO HCQ
Cathepsin B
Lamp-1
CO H2O2
Acridine Orange
10 µm 
10 µm 
Figure 1 LMP detection by immunoﬂuorescence in cell culture. (a) HeLa cells were treated with 30 mg/ml hydroxychloroquine (HCQ)
for 3 h, ﬁxed and stained for immunoﬂuorescence detection of cathepsin B (red) and Lamp1 (green). Note that after LMP, cathepsin B
diffuses throughout the cytosol. (b) 3T3 ﬁbroblasts were cultured for 3 h with 150mM H2O2 and stained for 15min with 10 mg/ml
acridine orange. Note the loss of the punctate red staining of acidic organelles after H2O2 treatment. LMP, lysosomal membrane
permeabilization.
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ﬂuorescent dextrans and observing the cytosolic release
of the dye after lysosomal insult. Dextrans of different
molecular weights can be used to assess the selectivity of
lysosomal permeabilization (Bidere et al., 2003).
Other methods to assess LMP are based on the use of
lysosomotropic ﬂuorochromes. Lysosomotropic probes
such as the Lysotracker dyes from Invitrogen (Carlsbad,
CA, USA) accumulate inside acidic organelles (which
include lysosomes and late endosomes) and can be
visualized by ﬂuorescence microscopy or ﬂow cytometry
(De Milito et al., 2007). Decreased Lysotracker ﬂuores-
cence may reﬂect LMP and/or an increase in lysosomal
pH, meaning that this method is not absolutely speciﬁc
for LMP. Following LMP, cells manifest less cytosolic
puncta by ﬂuorescence microscopy and appear weakly
ﬂuorescent when analysed by ﬂow cytometry (Boya
et al., 2003b). Some Lysotracker probes are compatible
with aldehyde ﬁxation and thus may be combined with
the immunoﬂuorescence detection of proteins.
Another probe used to measure the functional state of
lysosomes is acridine orange (AO). AO is a lysosomo-
tropic metachromatic ﬂuorochrome. When excited with
blue light, AO emits red ﬂuorescence at high concentra-
tions (when it is present in lysosomes) and green
ﬂuorescence at low concentrations (when it is present
in the cytosol and the nucleus) (Figure 1b). AO-loaded
cells manifest reduced red ﬂuorescence and increased
green ﬂuorescence after LMP (Antunes et al., 2001). AO
may be used either in live ﬂuorescence microscopy or
ﬂow cytometry (Boya et al., 2003a; Michallet et al.,
2004; Trincheri et al., 2007).
Lysosomal membrane permeabilization: complete
or partial
Lysosomal membrane permeabilization is one mechan-
ism for the induction of cell death. As mentioned above,
complete disruption of lysosomes provokes uncon-
trolled cell death by necrosis. In contrast, partial and
selective LMP induces the controlled dismantling of the
cell by apoptosis. Several reports indicate that, in
response to some lethal stimuli, not all lysosomes are
permeabilized at the same time, although the mechan-
isms explaining this heterogeneity remain elusive. Large
lysosomes seem to be particularly susceptible to the
action of LMP-inducing agents (Ono et al., 2003). In
addition, the production of intracellular mediators such
as reactive oxygen species (ROS), which have a spatially
limited range of activity, may induce the permeabiliza-
tion of lysosomes only in those subcellular regions that
are near to mitochondria, the major ROS-generating
organelles. Therefore, lysosomes that are localized in the
proximity of uncoupled mitochondria are more likely to
suffer damage to their membranes than distant lyso-
somes. Moreover, lysosomes constitute the principal
reservoir of chelatable iron, which accumulates upon the
autophagic degradation of iron-containing proteins
including mitochondrial cytochromes and ferritin.
Iron-catalysed Fenton reactions, which produce highly
reactive pro-oxidants, thus may damage lysosomal
membranes. Iron overload, as it occurs in some
pathologies and aging processes, can increase the
susceptibility of lysosomes to LMP (Mak and Weglicki,
1985; Link et al., 1993).
A second important question regarding LMP is
whether it occurs through non-selective rupture of the
membrane or whether speciﬁc pores are formed that
allow for the selective translocation of molecules up to a
certain size through the partially permeable lysosomal
membrane. Through the use of ﬂuorescently labeled
dextran molecules of different sizes (Bidere et al., 2003),
the induction of LMP by staurosporine was shown to
release low-molecular weight dextrans into the cytosol
(10 and 40 kDa), but not larger molecules (dextrans of
70 and 250 kDa). Accordingly, the hexosaminidase
enzyme (a 250 kDa protein normally resident in lyso-
somes) was retained within these organelles (Bidere
et al., 2003), in conditions in which CB, CL (both
B37 kDa) and CD (44 kDa) were released. Nevertheless,
it is currently unclear whether such a molecular sieve
effect can be mediated by proteinaceous pores present in
lysosomal membranes. A number of reports indicate
that different cathepsins (CB, CL and CD) simulta-
neously translocate after LMP is induced (Kagedal
et al., 2001a; Bidere et al., 2003; Zhao et al., 2003;
Michallet et al., 2004; Chen et al., 2005; Laforge et al.,
2007), although in most of the studies the inhibition or
genetic ablation of a single cathepsin isoform was
sufﬁcient to retard cell death (Kagedal et al., 2001a;
Bidere et al., 2003; Laforge et al., 2007). Moreover, in
some cases in which cathepsins were detected in the
cytosol, lysosomes still could be labeled with lysosomo-
tropic ﬂuorochromes, indicating that the cytosol–lyso-
some pH gradient was maintained (Bidere et al., 2003)
and that LMP may occur selectively in a subset of
lysosomes. It remains a matter of speculation whether
special transporters are responsible for the selective
relocation of lysosomal proteins or whether transient
pores are formed that lead to the release of proteins up
to a maximum size, then reclose and facilitate rebuilding
of a proton gradient. In the outer mitochondrial
membrane, proapoptotic proteins Bax and Bak may
form transient pores that allow for the translocation of a
number of molecules larger than 100 kDa without
provoking a rupture of the membrane (Kuwana et al.,
2005). According to some reports, Bax is also capable of
inducing LMP by acting directly on the lysosomal
membrane (Kagedal et al., 2005; Feldstein et al., 2006).
Nonetheless, the implication of proteins from the Bcl-2
family in LMP has not been studied extensively thus far.
Inducers of LMP
A large panel of distinct agents and molecules can
induce LMP (Table 1 and Figure 2), although the best-
studied mechanism of LMP is ROS-mediated lysosomal
destabilization (Terman et al., 2006). Indeed, enhanced
ROS generation precedes LMP and cell death in many
settings. Indirect damage to the lysosomal membrane by
ROS is mediated by the intralysosomal accumulation of
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iron (Eaton and Qian, 2002). Free iron catalyses the
conversion of hydrogen peroxide (which freely crosses
membranes) into hydroxyl radicals. Accordingly, iron
loading increases the fragility of lysosomal membranes
(Mak and Weglicki, 1985; Link et al., 1993). Conversely,
desferrioxamine mesylate, an iron chelator that speciﬁ-
cally accumulates inside lysosomes by ﬂuid-phase
endocytosis, can inhibit lysosomal-mediated cell death
induced by oxidant challenge (Doulias et al., 2003;
Yu et al., 2003; Kurz et al., 2006). A positive feedback
loop between LMP and mitochondrial damage exists
during oxidation-induced cell death, suggesting that
both iron chelation in lysosomes and inhibition of ROS
production by mitochondria may have cytoprotective
effects (Terman et al., 2006).
Another putative mediator of LMP is the sphingolipid
sphingosine. As a lipophilic weak base, sphingosine is
lysosomotropic. Upon protonation, sphingosine accu-
mulates within the acidic compartment where it may act
as a detergent. Limited doses of sphingosine induce a
cascade of lethal events including LMP, caspase
activation, as well as the dissipation of the mitochon-
drial inner transmembrane potential (Kagedal et al.,
2001a). High doses of sphingosine rapidly cause
extensive lysosomal rupture culminating in rapid necro-
sis (Kagedal et al., 2001b). The intracellular levels of
sphingosine increase after TNF-a (tumor necrosis factor
alpha) treatment, particularly in the liver where sphin-
gosine has been implicated in LMP. TNF-a or
sphingosine induces LMP in CBþ /þ but not CB/
hepatocytes in vitro, and sphingosine permeabilizes
hepatocyte lysosomes isolated from CBþ /þ but not
CB/ livers as assessed by Lysotracker (Werneburg
et al., 2002). In addition, the overexpression of a
dominant-negative factor associated with neutral sphin-
gomyelinase activation (FAN) reduces LMP, CB
translocation and diminishes apoptosis in a rat hepatoma
cell line (Werneburg et al., 2004).
Free fatty acids and bile salts can also induce LMP-
dependent cell death (Roberts et al., 1997; Feldstein
et al., 2004, 2006). Glycochenodeoxycholate is the
primary bile salt induced during cholestasis. When
added to a rat hepatoma cell line, glycochenodeoxycho-
late induces LMP, CB translocation, caspase activation
and cell death, which can be effectively blocked by
caspase inhibition and overexpression of the cathepsin
inhibitor cystatin A (Jones et al., 1998). This pathway
seems to play a prominent role in animal models of
Table 1 Inducers of LMP
Inducer Example Mechanisms Reference
ROS H2O2, napthazarine, redox cycling
quinones, fenretinide
Chemical modiﬁcation of
lysosomal membrane lipids?
Terman et al. (2006)
Lysosomotropic agents Sphingosine, hydroxychloroquine,
MDL-72,527, LCL204, BPC,
N-dodecyl-imidazole, 3-aminopropanal
LMP due to detergent-like
effects.
Kagedal et al. (2001a);
Yu et al. (2003);
Boya et al. (2003b)
Detergents (MSDH, siramesine) Li et al. (2000);
Ostenfeld et al. (2005)
Antibiotics (norﬂoxacin,
cyproﬂoxacin)
Boya et al. (2003a)
Lipids Fatty acids, bile salts,
cholesterol oxidation products,
palmitate,
HePC
Feldstein et al. (2006);
Paris et al. (2007)
Bcl-2 family proteins Bax Formation of proteaceous
pores within lysosomal
membranes?
Kagedal et al. (2005);
Feldstein et al. (2006)
Caspases Caspase-9, caspase-8 Digestion of lysosomal
proteins or indirect effects?
Werneburg et al. (2004);
Gyrd-Hansen et al. (2006)
Cathepsins Cathepsin B Digestion of lysosomal
proteins?
Werneburg et al. (2002)
Microtubule toxins Vincristine, vinorelbine,
vinblastine, epothilone B,
paclitaxel
Unknown Groth-Pedersen et al. (2007)
Photodamage NPe6, ATXs10 Lysosomal membranes Xue et al. (2003);
Ichinose et al. (2006)
Poyphenols Resveratrol Unknown Trincheri et al. (2007)
Receptors CD3, PHA, TRAIL, TNF-a Unknown Guicciardi et al. (2000);
Heinrich et al. (2004)
Lysosomal proteins LAPF Pores? Chen et al. (2005);
Li et al. (2007)
DNA damage p53, camptothecin, etoposide Unknown Emert-Sedlak et al. (2005);
Paquet et al. (2005)
Silica ROS? Unknown Thibodeau et al. (2004);
Hamilton et al. (2007)
Toxins Cobra venom, yesotoxin,
crotoxin
Direct effect on lysosomal
membranes?
Feofanov et al. (2005);
Malagoli et al. (2006);
Yan et al. (2006)
Abbreviations: LMP, lysosomal membrane permeabilization; ROS, reactive oxygen species; TNF-a, tumour necrosis factor alpha.
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cholestasis where CB inactivation attenuates liver injury
(Roberts et al., 1997; Canbay et al., 2003).
Hexadecylphosphocholine is an experimental antic-
ancer agent that induces cell death through a lysosomal
pathway characterized by partial lysosomal rupture and
CB relocation. In this model, the overexpression of Bcl-2
and the addition of the pan caspase inhibitor Q-VD-
OPH inhibit lysosomal rupture, but only at early time
points, suggesting that lysosomal rupture is ampliﬁed by
caspases and proapoptotic Bcl-2 family proteins, yet
does not entirely rely on them in this system (Paris et al.,
2007). Thus, depending on the speciﬁc lipid, LMP
induction may be a primary event (upstream of caspase
activation) or occur downstream of the initiation of the
apoptotic cascade.
The oxidation products of cholesterol are capable of
inducing LMP, CD translocation and apoptotic cell
death in macrophages (Yuan et al., 2000). Several
reports indicate that lysosomes are destabilized in
macrophages exposed to oxidized low-density lipopro-
tein or 7b-hydroxycholesterol, which produces leakage
of lysosomal enzymes into the cytosol (CB, CD and CL)
and apoptotic cell death. These effects are reversed by
pre-exposing cells to the iron chelator, desferrioxamine
(Li et al., 1998; Yuan et al., 2000; Li and Yuan, 2004).
The cell death pathway following exposure to
7b-hydroxycholesterol or 7b-hydroxysitoesterol, the major
oxidation products from cholesterol and plant sterols, is
associated with LMP (Roussi et al., 2007). However, the
cell death mechanism induced by each compound differs
insofar as 7b-hydroxycholesterol induces ROS accumu-
lation, extensive MOMP and endonuclease G expres-
sion, whereas 7b-hydroxysitoesterol does not induce any
of these events (Roussi et al., 2007). LMP occurs after
exposing cells to these lipid oxidation products, more so
in response to 7b-hydroxysitoesterol than in response
to 7b-hydroxycholesterol. These two hydroxyphenols
exhibit different lipophilic properties despite their very
similar structure (Roussi et al., 2007), indicating
that slight variations in the hydrophobicity of lipid
derivatives may have a strong inﬂuence on the cell death
pathway that they activate.
Other examples of lysosomotropic detergents are
N-dodecylimidazole and O-methyl-serine dodecylamide
hydrochloride, which both induce LMP followed by
caspase-3-dependent apoptosis at low doses (Li et al.,
2000; Zhao et al., 2003) and necrosis (without caspase
activation) at high doses (Li et al., 2000). Siramesine is
a sigma-2 receptor ligand that was initially developed
to treat anxiety and depression. Its structure involves
an amphiphilic amine, suggesting that it can act as
lysosomotropic detergent. Indeed, siramesine induces a
rise in lysosomal pH followed by LMP, CD release and
caspase-independent cell death, which can be blocked by
antioxidants and CB inhibitors yet does not require
sigma-2 receptors (Ostenfeld et al., 2005). L-leucyl-L-
Nucleus
DNA
damage
Cytosol
LMP
p53
p53
Lysosome
TNF-α
TRAIL
ROS
PLA2
Lysosomotropic
detergents
Photodamage
PDT
Sphingosine
Bax
Staurosporine
CB
Microtubule
poisons
Viral
proteins
Bacterial
proteins
Fenton
Reactions
death
receptors
Caspases
FAN
Plasma membrane
Figure 2 Pathways leading to the induction of LMP. For details see text. CB, cathepsin B; FAN, factor associated with neutral
sphingomyelinase activation; LMP, lysosomal membrane permeabilization; PDT, photodynamic therapy; TNF-a, tumor necrosis
factor alpha.
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leucine-methyl ester is taken up by cells through
receptor-mediated endocytosis and accumulates inside
lysosomes, thus inducing LMP, cathepsin release,
cleavage of Bid, MOMP- and caspase-dependent apop-
tosis (Uchimoto et al., 1999; Cirman et al., 2004).
The activation of phospholipase A2 also induces
LMP as the phospholipase A2 inhibitor 4-bromophe-
nacyl bromide diminishes lysosomal rupture and apop-
tosis in a lymphoma cell line (Zhao et al., 2001a, 2003;
Marchi et al., 2004). Interestingly, lysosomal enzymes
activate phospholipase A2, thereby providing a positive
feedback loop (Zhao et al., 2001a). Phospholipase A2
also induces MOMP, ROS production and cytochrome
c release, providing an efﬁcient means to induce cell
death by acting directly on lysosomes and mitochondria.
The Bcl-2 family of proteins are important apoptotic
regulators as they are able to control MOMP (Youle
and Strasser, 2008). After their activation and translo-
cation to mitochondria, proapoptotic members of the
family such as Bax and Bak induce MOMP, and
this process is blocked by antiapoptotic members of
the family such as Bcl-2 and Bcl-XL. Moreover, when
proteins from the BH3-only family, such as Bid, are
activated, they interact with multidomain proteins of the
Bcl-2 family, as well as with other mitochondrial
proteins to promote apoptosis (Zamzami et al., 2000;
Youle and Strasser, 2008). The effects of Bcl-2 proteins
are not conﬁned to the regulation of MOMP; they also
affect calcium homeostasis of the endoplasmic reticu-
lum, autophagy and the unfolded protein response (Hetz
and Glimcher, 2008). Recently, the proapoptotic Bcl-2
family member Bax has been shown to exert a direct
effect on lysosomes. Thus, Bax can translocate from the
cytosol to lysosomal membranes and induce LMP
(Kagedal et al., 2005). Fibroblasts cultured in the
presence of the proapoptotic pan-tyrosine kinase in-
hibitor staurosporine exhibit a conformational change
in Bax and its translocation to lysosomes, resulting in
LMP and CD translocation to the cytosol (Kagedal
et al., 2005). The requirement of Bax for LMP has been
demonstrated by comparing Baxþ /þ and Bax/ hepato-
cytes exposed to long-chain fatty acids (Feldstein et al.,
2006). Thus, palmitate induces a conformational change
in Bax that is typically linked to apoptosis (and that is
detected by means of a monoclonal antibody that
interacts with Bax only in its ‘apoptotic’ conformation,
when the N terminus is exposed), resulting in the
translocation of Bax to lysosomes. Indeed, genetic
ablation of Bax expression and increased Bcl-XL
expression protect cells from palmitate-induced LMP
and death (Feldstein et al., 2004, 2006). Moreover,
TRAIL has been recently shown to induce cell death in
several cell lines following a pathway that involves the
apical caspase-8-dependent JNK activation, which then
induces the translocation of Bax and Bim (a BH3-only
protein from the Bcl-2 family) to lysosomal membranes
followed by LMP (Werneburg et al., 2002). All these
events occur upstream of mitochondrial changes (such
as cytochrome c release and loss of the mitochondrial
transmembrane potential), suggesting that the two
proapoptotic Bcl-2 family members, Bim and Bax, can
induce LMP independently from and upstream
of MOMP. siRNA-mediated downregulation of Bax
expression has also been shown to protect cells from
LMP and cell death after a hydrogen peroxide insult
(Castino et al., 2007). From studies of Bid/ cells, it
appears clear that the TNF-a-mediated LMP and cell
death of hepatocytes is Bid dependent (Guicciardi et al.,
2005). All these data suggest that Bcl-2 family members
might modulate LMP in a similar way to their
regulation of MOMP.
Other more recently identiﬁed LMP regulators are
caspases, the activation of which has been shown to
induce LMP-dependent apoptosis in response to some
stimuli. For instance, TNF-a can induce LMP through
caspase-8 and FAN, and the resulting CB translocation
then accounts for cell death. Reportedly, FAN acts
upstream of caspase-8 and Bid in a signaling cascade
that culminates in lysosomal permeabilization (Werne-
burg et al., 2004; Nagaraj et al., 2006). Moreover, FAN
has recently been shown to regulate the size of
lysosomes (Mohlig et al., 2007). Interestingly, FAN
has striking structural homology with Lyst (lysosomal
trafﬁcking regulator), a BEACH protein mutated in
Chediak-Higashi syndrome, which is a lysosomal
storage disease characterized by severe immunological
defects and peripheral neuropathies, and that is often
diagnosed because of the presence of large lysosomes
(Ward et al., 2000). Caspases are activated upstream of
LMP after TNF-a treatment of ME-180 cells but not
after an identical treatment of WEHI-S cells, indicating
that the relative hierarchical position of LMP and
caspase activation depends on the cell type (Foghsgaard
et al., 2001). Caspases are activated in a mitochondria-
dependent manner in many cell settings, as the ﬁnal
result of cytochrome c release from mitochondria and
the formation of a multiprotein complex called the
apoptosome. This complex, which is composed of
cytochrome c as well as Apaf-1, results in the recruitment
and allosteric activation of caspase-9, which then activates
caspase-3 (Riedl and Salvesen, 2007). When mouse
embryonic ﬁbroblasts are challenged with TNF-a, cas-
pase-9 can be activated through another Apaf-1-indepen-
dent cell death cascade that involves LMP-dependent
cathepsin activation, as well as caspase-8-dependent
caspase-9 activation (Gyrd-Hansen et al., 2006). In this
cell type, caspase-9 has been identiﬁed as a new molecular
link between the receptor-proximal caspase-8 activation
and LMP. In contrast, proteins such as Bid and Bax do
not seem to have any major function in the induction of
LMP in TNF-a-stimulated mouse embryonic ﬁbroblasts
(Gyrd-Hansen et al., 2006). Thus, TNF-a can induce
different effectors to induce cell death depending on the
cell type, as seen in combination treatments with IFN-g
(Li and Pober, 2005).
Interestingly, cathepsins have also been implicated as
inducers of LMP. Hepatocytes from CB/ mice display
less LMP after exposure to TNF-a, which may reﬂect
the direct induction of LMP by CB (either acting from
inside or outside the lysosome) or the existence of an
ampliﬁcation loop in which LMP induces CB activation,
and CB then triggers further LMP (Werneburg et al.,
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2002). Indeed, in an in vitro assay using isolated
lysosomes, sphingosine was capable of permeabilizing
liver lysosomes that had been isolated from CBþ /þ livers
but not from CB/ hepatocytes (Werneburg et al.,
2002). Similarly, the transfection-enforced overexpres-
sion of an endogenous CB inhibitory protein, Spi2a, can
reduce LMP in TNF-a-treated cells (Liu et al., 2003).
In a model of acute H2O2 stress affecting primary
alveolar type II cells, cathepsin inhibitors also reduce the
extent of LMP (Yin et al., 2005). Altogether, these data
suggest that the lysosomal enzymes (CB and CD) may
directly attack lysosomes (from inside or outside?) and
facilitate LMP-mediated cell death. In addition, other
proteases like calpains can induce lysosomal destabiliza-
tion and LMP-dependent cell death, as this is suggested
by the use of calpain inhibitors in stressed cells (Yap
et al., 2006; Cheung et al., 2007).
There is some evidence that p53 can induce LMP
upstream of MOMP, as indicated by experiments in cells
expressing a thermolabile form of p53. When such cells
are shifted from 37 1C (when p53 is destroyed) to 32 1C
(when p53 accumulates), they manifest sequential LMP
and MOMP (Yuan et al., 2002). Recently, a new
adaptor protein capable of translocating to the lysoso-
mal membranes and inducing LMP has been described
(Chen et al., 2005). This protein, which is called LAPF
(lysosome-associated protein containing PH and FYVE
domains), belongs to the family of phaﬁns and induces
LMP-, MOMP- and caspase-independent cell death
(Chen et al., 2005). After TNF-a exposure and ionizing
irradiation, LAPF speciﬁcally interacts with phosphory-
lated p53 and induces LMP. Silencing LAPF expression
abrogates the lysosomal translocation of phosphory-
lated p53, whereas silencing p53 has no effect on the
lysosomal translocation of LAPF (Li and Baker, 2007).
Like LAPF silencing, silencing endogenous p53 expres-
sion in L929 cells can signiﬁcantly impair TNF-a-
induced LMP and apoptosis. Hence, phosphorylated
p53 might translocate to the lysosome while forming a
complex with the LAPF adaptor protein, locally
stimulate LMP and ﬁnally induce apoptosis in a
transcription-independent manner (Chen et al., 2005;
Li and Baker, 2007). However, p53 can also translocate
to mitochondria and induce permeabilization of the
outer mitochondrial membrane by forming complexes
with the multidomain proteins from the Bcl-2 family,
resulting in cytochrome c release (Mihara et al., 2003;
Chipuk et al., 2004). Thus, it is tempting to speculate
that p53 can recruit LAPF, and perhaps Bcl-2 family
members, to induce LMP in a manner similar to that in
which it triggers MOMP.
The apoptotic response of T lymphocytes stimulated
by phytohemagglutinin and anti-CD3 in T lymphocytes
is thought to mimic peripheral T-cell deletion induced
by high-dose immune tolerance. This model of T-cell
death has been shown to involve rapid LMP with CB
and CL translocation that occurs before phosphatidyl-
serine exposure on the outer leaﬂet of the plasma
membrane and nuclear chromatin condensation
(Michallet et al., 2004). Caspase inhibition blocked
nuclear pyknosis but had no effect on phosphatidyl-
serine exposure. In addition, cell death was only
prevented by incubating the cells in the presence of CB
inhibitors but not with inhibitors of CD or calpains. The
mitochondrial release of cytochrome c was observed at a
late stage, suggesting that MOMP was not required
for inducing cell death in this model (Michallet et al.,
2004). However, this speculation awaits experimental
veriﬁcation.
A range of different viral proteins kill infected cells by
facilitating the induction of MOMP (Boya et al., 2004).
In addition, several viral proteins such as Nef from
human immunodeﬁciency virus-1, protein U7 from
human papillomavirus type-16, parvovirus H1 and
herpes simplex virus infection induce LMP- and
cathepsin-dependent cell death (Kaznelson et al., 2004;
Di Piazza et al., 2007; Laforge et al., 2007). Cystatin C
can block the enhanced CB activity observed in herpes
simplex virus type-1-infected cells and concomitantly
inhibits herpes simplex virus type-1 replication and
host cell apoptosis (Peri et al., 2007). The protein E7
encoded by human papillomavirus type-16 can induce
caspase-dependent apoptosis in different cell lines.
However, in U2OS cells, this protein alone does not
induce apoptosis unless the cell-cycle regulator p21 is
overexpressed, in which case E7 triggers CB-dependent
cell death. This cell death is characterized by LMP and
CB translocation, which is completely inhibited by the
CB inhibitor CA074Me (Kaznelson et al., 2004).
Mycobacterium tuberculosis-infected macrophages un-
dergo cathepsin-dependent caspase-independent cell
death (Lee et al., 2006), and infection with Bacillus
Calmette-Gue´rin also induces LMP and cell death
(Sandes et al., 2007). A recent report indicates that
virulent strains ofM. tuberculosis andM. leprae (but not
M. bovis and Bacillus Calmette-Gue´rin) translocate
from lysosomes to the cytosol, which then can cause
apoptotic cell death within a week (van der Wel et al.,
2007). Thus, it is tempting to speculate that LMP may
proceed in this setting and that intracellular pathogens
have evolved mechanisms to exploit the lysosomal
pathway for cell death induction.
Drugs that act on microtubules can also induce LMP-
and caspase-independent cell death. This applies to
microtubule destabilizing vinca alkaloids such as vin-
cristine, vinorelbine and vinblastine (Groth-Pedersen
et al., 2007), as well as to compounds that stabilize
microtubules such as paclitaxel, epothilone B and
dicodermoliede. All these agents reportedly induce
LMP- and CB-dependent apoptosis (Broker et al.,
2004; Groth-Pedersen et al., 2007). The general applic-
ability of these ﬁndings, however, remains to be
conﬁrmed.
Proton pumps like the vacuolar-type H ATP-ase are
involved in the control of cellular pH in normal and
tumor cells, and they are targeted for the treatment of
gastroesophageal acid-related diseases. Proton pump
inhibitors, such as ompeprazole, are weak bases that
accumulate inside lysosomes (De Milito et al., 2007).
Proton pump inhibitors induce the early production of
ROS that precedes the alkalinization of lysosomal pH,
LMP and cytosol acidiﬁcation, as well as caspase-
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independent cell death in B cells. Interestingly, cathepsin
translocation occurred very late in ompeprazole-treated
cells, and cathepsin inhibitors failed to protect from
apoptosis, whereas the antioxidant N-acetylcysteine did
protect the cells from LMP and cell death (De Milito
et al., 2007). Thus, the participation of LMP in lethal
signaling remains to be demonstrated in this model.
Endogenous inhibitors of lysosome-mediated cell death
Heat-shock (Hsp)70 proteins function as ATP-depen-
dent chaperones that regulate the folding of newly
synthesized proteins, the assembly of multiprotein
complexes and the transport of proteins across cellular
membranes (Daugaard et al., 2007b). Hsp70 is fre-
quently overexpressed in malignant tumors, and this
overexpression is associated with a poor therapeutic
outcome in human breast cancer (Daugaard et al.,
2007b). Hsp70 has a marked cytoprotective effect and
inhibits apoptotic signaling by inhibiting MOMP, by
reducing caspase activation or by neutralizing AIF
(Garrido et al., 2006). Hsp70 also localizes to lysosomal
membranes (Rohde et al., 2005) and can protect
lysosomal membranes against LMP induced by different
stimuli such as etoposide, TNF-a and oxidative stress
(Nylandsted et al., 2004) (Table 2). In addition, Hsp70
depletion mediated by antisense constructs or small
interfering RNAs induces caspase-independent cell
death of cancer cells but not of non-tumorigenic cells
(Nylandsted et al., 2000). The speciﬁc depletion of one
protein of the Hsp70 family, Hsp70-2, triggers LMP-
and cathepsin-dependent cell death (Daugaard et al.,
2007a). This pathway seems to be mediated by the lens
epithelium-derived growth factor, which is a transcrip-
tional co-activator that regulates the transcription of
several stress genes including Hsp70-2 and that
confers protection against several proapoptotic stimuli
(Ganapathy et al., 2003). Knockdown of lens epithe-
lium-derived growth factor induces destabilization of
lysosomal membranes and caspase-independent cell
death that cannot be avoided by Bcl-2 overexpression.
Conversely, lens epithelium-derived growth factor upre-
gulation protects lysosomal membranes and inhibits cell
death induced by agents like siramesine, etoposide and
TNF-a. Thus, lens epithelium-derived growth factor
regulates LMP and cell death, presumably by regulating
Hsp70-2 expression (Groth-Pedersen et al., 2007).
Sphingomyelin and some of its derivatives (for
example, 3-O-methylsphingomyelin, an inhibitor of
neutral sphingomyelinase) can stabilize lysosomes
against the lysosomal photosensitizer, N-aspartyl chlorin
e6, which causes rapid loss of AO staining of acidic
organelles, release of CD from late endosomes/lyso-
somes and the activation of procaspase-3, as well as
TNF-a-induced LMP and cell death (Caruso et al.,
2005). These results point to the possibility that
proteins, as well as non-proteinaceous molecules, act
as endogenous regulators of LMP.
A host of proteins act as endogenous inhibitors of
cathepsins and hence may avoid cell death after LMP,
by neutralizing cathepsins that have been released into
the cytosol. Cystatins are endogenous inhibitors of
lysosomal cysteine proteases and they act as endogenous
protectors of leakage after LMP by trapping and
inhibiting cathepsins, protecting the cell from their
protease activity. Cystatins are not very selective and
inhibit endopeptidases in the picomolar range and
exopeptidases in the nanomolar range (Turk et al.,
2001). Serpins (serine protease inhibitors) are a family of
protease inhibitors that act either at the extracellular or
at the intracellular levels (Silverman et al., 2001; Law
et al., 2006). The majority of serpins inhibit serine
proteases, although some of them can inhibit caspases
and cysteine proteases from the papain family, such as
cathepsins B, L and K (Law et al., 2006). Some
intracellular members of the serpin family are able to
block LMP-dependent cell death. Serpin 2A has been
shown to block caspase-independent, LMP- and CB-
dependent cell death triggered by TNF-a (Liu et al.,
Table 2 Inhibitors of LMP or post-LMP effector mechanisms
Name Target Type Reference
Hsp70 family of
proteins
LMP Chaperone Gyrd-Hansen et al. (2004);
Daugaard et al. (2007b)
Deferioxamine ROS, LMP Iron chelator Kurz et al. (2006)
a-tocopherol ROS, LMP Antioxidant Bivik et al. (2007)
N-acetyl cysteine ROS, LMP Antioxidant De Milito et al. (2007)
Vitamin C ROS, LMP Antioxidant Roussi et al. (2007)
Bcl-2 Bax, Bid, LMP Antiapopotic Bcl-2
family protein
Zhao et al. (2001b)
3-O-methylsphingomyelin Neutral sphingomyelinase Lipid Caruso et al. (2005)
Cystatins Cystein proteases Protease inhibitors Jones et al. (1998); Peri et al. (2007)
Serpins Serin proteases
(caspases)
Protease inhibitors Liu et al. (2004c)
E64d, CA074Me, R3032 Cathepsin B Protease inhibitors Werneburg et al. (2002);
Michallet et al. (2004);
Nagaraj et al. (2006)
Pepstatin A Cathepsin D Protease inhibitor Roberg et al. (1999)
Aryl hyrdrocarbon receptor Lysosomal membrane? Steroid receptor Caruso et al. (2006)
Abbreviations: LMP, lysosomal membrane permeabilization; ROS, reactive oxygen species.
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2004c). Moreover, serpin 2A, a transcriptional nuclear
factor-kB target, is upregulated in memory T-cell
precursors, facilitating memory T-cell development by
blocking CB-dependent cell death (Liu et al., 2004b).
Another member of the serpin family, hurpin, blocks CL
but not CB and confers resistance to ultraviolet light-
induced apoptosis in human keratinocytes (Welss et al.,
2003). Recently, an intracellular serpin from C. elegans,
SRP-6, has been shown to protect against cell death
induced by hypotonic shock, hypoxia, heat shock and
paraquat, which are all stimuli that reportedly induce
lysosomal rupture and cysteine protease-dependent cell
death in worms (Abraham and Shaham, 2007; Luke
et al., 2007). Thus, serpins act as physiologically relevant
inhibitors of LMP-mediated cell death.
Recently, overexpression of cFLIP has been shown to
stimulate the p42/44 MAP-kinase pathway and to
protect hepatocellular carcinoma cells from TRAIL-
induced LMP and apoptosis (Guicciardi et al., 2007).
Moreover, pharmacological inhibition of p38, transfec-
tion with a p38a dominant-negative mutant or knockout
of the p38a gene (in mouse embryonic ﬁbroblasts)
protects cells from apoptosis induced by the lyso-
somotropic photosensitizing compound, tetrakis-meso-
(4-ethyleneglycol-2,3,5,6-tetraﬂuorophenyl) porphyrin
(Kralova et al., 2007). The molecular mechanism by
which p38 MAPk regulates LMP and cell death remains
elusive, although it may be related to p38 binding to
lysosomes and endosomes through an interaction with
p14 and MP1 proteins (Kolch, 2005).
Downstream signals leading to cell death after LMP
Depending on the lethal stimulus, the extent of LMP, the
amount and type of cathepsins released into the
cytoplasm, as well as the abundance of cathepsin
inhibitors, LMP can trigger a variety of death-associated
morphologies ranging from classical apoptosis to necro-
sis. Thus, LMP associated with cathepsin translocation
may directly activate calpains and caspases, but LMP
may also trigger the classical MOMP–caspase pathway,
as well as MOMP- and caspase-independent apoptosis.
Which lethal pathways are stimulated by LMP is
inﬂuenced by the cellular context, including the cell type,
the immortalization status and the genetic background.
The main downstream signaling pathways leading to cell
death after LMP are summarized in Figure 3.
As stated above, ROS are among the principal
inducers of LMP. ROS-dependent LMP often initiates
a cell death pathway that involves sequential CD
translocation, MOMP with cytochrome c release and
caspase-dependent apoptosis. Antioxidants, such as
desferrioxamine mesylate, N-acetylcysteine and a-toco-
pherol, block LMP and hence prevent all subsequent
steps of the apoptotic cascade (Zang et al., 2001).
Endogenous CB inhibitors such as cystatins block CB
protease activity in paradigms of ROS-induced LMP-
dependent cell death, which points to the involvement of
CD (rather than CB) in this pathway. Thus, cystatin C
upregulation has been observed in PC12 cells following
6-hydroxydopamine exposure, a classical model of
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Figure 3 Lethal pathways activated after LMP. Note that a variety of different effector molecules can trigger a range of distinct
modalities of cellular dismantling. The dominant pathway depends on the intensity of LMP, on the expression level of lysosomal
hydrolases, the cytosolic concentrations of cathepsin inhibitors, the functional state of mitochondria, the concentration of caspases and
their antagonists, as well as multiple additional factors. AIF, apoptosis-inducing factor; CB, cathepsin B; CD, cathepsin D; Cyt. c,
cytochrome c; LMP, lysosomal membrane permeabilization; MOMP, mitochondrial outer membrane permeabilization.
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ROS-mediated toxicity in which CD translocates to the
cytosol and induces caspase-dependent cell death (Lee
et al., 2006). However, in other paradigms, CB does play
a role in linking LMP to cell death.
What are then the signals that link LMP to MOMP?
One prominent MOMP inducer is the BH3-only protein
Bid, which requires proteolytic cleavage to become
active. In vitro experiments performed at neutral pH
showed that the papain-like cathepsins B, H, L, S and K
cleave Bid predominantly at Arg(65) or Arg(71),
whereas cathepsins C and X were unable to cleave Bid
(Cirman et al., 2004). In addition, when full-length Bid
was treated with cathepsins B, H, L and S, the resulting
cleavage product was fully capable of releasing cyto-
chrome c from isolated mitochondria (Cirman et al.,
2004). CB-dependent Bid cleavage has been observed in
various cell lines such as glioma cells killed by
interleukin-24 (Yacoub et al., 2008), TTC bladder
cancer cells killed by Bacillus Calmette-Gue´rin (Sandes
et al., 2007), U2O2 osteosarcoma cells and oral
squamous cell carcinoma with TRAIL (Garnett et al.,
2007) (Nagaraj et al., 2006) and MCF-7 breast cancer
cells exposed to camptothecin (Lamparska-Przybysz
et al., 2006). Bid also represents a direct downstream
target of CD. Indeed, in cathepsin-deﬁcient ﬁbroblasts,
the TNF-mediated apoptotic response was blocked at
the level of Bid cleavage (Heinrich et al., 2004). The CD
inhibitor pepstatin A suppresses the cleavage of Bid by
lysosomal extracts from a murine hepatoma in a cell-free
system. Pepstatin A also delayed the induction of
apoptosis in cell cultures treated with TNF-a and
cycloheximide, which correlated with reduced Bid
cleavage and reduced activation of pro-caspases-3/7
(Caruso et al., 2006). In human neutrophils, ﬁmbriated
Escherichia coli bacteria can induce LMP- and CD-
dependent Bid cleavage (Blomgran et al., 2007). Thus,
CB- or CD-mediated Bid cleavage emerges as a key
connection between LMP and MOMP.
Several reports indicate that LMP can initiate a
caspase-independent cell death pathway, as caspase
inhibitors fail to block cell death. For example,
microtubule-stabilizing agents such as epothilone B,
discodermolide and paclitaxel reportedly induce
CB-dependent and caspase-independent cell death, as
evidenced by the signiﬁcant cytoprotection conferred by
the CB inhibitor CA074-Me (but not the broad-
spectrum caspase inhibitor Z-VAD-fmk) (Broker et al.,
2004). However, microtubule poisons have been shown
to induce either caspase-dependent or caspase-indepen-
dent cell death, depending on the cell type. Similarly,
TRAIL can induce LMP- and caspase-dependent
apoptosis (Werneburg et al., 2007) or LMP- and
caspase-8-independent cell death (Garnett et al., 2007),
depending on the cell type. Downregulation of Hsp70,
which protects lysosomal membranes from LMP-indu-
cing stimuli, induces caspase-independent cell death in
breast cancer cells (Nylandsted et al., 2000). Macro-
phages infected with high multiplicities of infection of
M. tuberculosis induce LMP and cell death that cannot
be blocked by caspase inhibitors (Lee et al., 2006). The
distal death effectors in these systems have not been
characterized in detail, although AIF has been shown to
be one of the main effectors of caspase-independent cell
death (Modjtahedi et al., 2006). During apoptosis, AIF
translocates from mitochondria to the nucleus where it
induces DNA degradation (Modjtahedi et al., 2006).
AIF has proapoptotic activity after LMP in activated
T lymphocytes following exposure to staurosporine
(Bidere et al., 2003) and after LAPF overexpression, a
lysosomal protein capable of inducing LMP-dependent
and caspase-independent apoptosis in mouse ﬁbrosar-
coma cells (Chen et al., 2005). Thus, AIF may be
responsible for promoting caspase-independent cell
death after LMP. Last, as a high level of oxidative
stress is a common occurrence during LMP induction,
caspases may become inactivated because of ROS-
mediated oxidation (Mannick et al., 2001).
In some cases, LMP and subsequent MOMP are
linked with each other by the activation of caspase-2. In
mouse hepatocytes, TNF-a triggers Bid-dependent
lysosomal permeabilization, followed by the release of
CB into the cytosol and the activation of caspase-2.
Caspase-2 then facilitates efﬁcient mitochondrial cyto-
chrome c release and apoptosis (Guicciardi et al., 2005).
In addition, the proteasome inhibitor bortezomid
induces CB release from lysosomes, activation of
caspase-2 and cell death (Guicciardi et al., 2005).
Caspase-2 activation is blocked when CB is inhibited,
suggesting that CB release occurs upstream of caspase-2.
Moreover, Z-VDVAD-FMK (a chemical inhibitor of
caspase-2) or depletion of caspase-2 with an siRNA
attenuated MOMP. Thus, caspase-2 emerges as a new
link between lysosomal and mitochondrial permeabili-
zation (Yeung et al., 2006). It remains to be determined
in which speciﬁc circumstances Bid and caspase-2 play
predominant roles in mediating post-LMP events such
as MOMP.
Cathepsin B has been shown to translocate to the
nucleus and induce cell death upon exposure of SHSY-
5Y cells to 3-aminopropanal, mouse hepatocytes to
TNF-a or rat hepatocytes to glycochenodeoxycholate
(Roberts et al., 1997, 2000; Li et al., 2003). There is some
evidence that CB can induce direct nuclear damage from
studies in which puriﬁed CB induces rapid chromatin
condensation in isolated HeLa nuclei (Vancompernolle
et al., 1998). Interestingly, this effect was abolished
when CB was preincubated with 2 mM zVAD-fmk, a
concentration at which only caspase activity is inhibited.
Thus, the proapoptotic effect of CB may depend on
secondary caspase activity.
The most common cathepsins implicated in cell death
are CB and CD, although CL can also induce caspase-3
activation (Ishisaka et al., 1999; Hishita et al., 2001). In
addition, CL has an important function in the cell death
associated with the involution of the mammary gland
after weaning, as CL inhibitors reduce cell death in this
system (Burke et al., 2003). Cathepsin G is normally
expressed in macrophages and other myeloid cells, and it
has been implicated in the antibacterial effect of
polymorphonuclear leukocytes. Cathepsin G staining
becomes diffuse during ultraviolet light-induced apop-
tosis of leukemia cells, and cathepsin G may be
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implicated in the proteolytic degradation of the Hbrm
protein, which is implicated in chromatin remodeling
(Biggs et al., 2001). Chymotrypsin B is a digestive
protease secreted by the exocrine pancreas that has
recently been implicated in apoptotic cell death of
hepatocytes treated with TNF-a. Chymotrypsin B
translocates from lysosomes to the cytosol and induces
a mitochondrial pathway of apoptosis that is signiﬁ-
cantly blocked by RNA interference of chymotrypsin B
or by pretreatment with the chymotrypsin B inhibitor,
N-p-tosyl-L-phenylalanine chloromethyl ketone. These
results demonstrate that chymotrypsin B can function as
a proapoptotic protease in the LMP-initiated cell death
pathway (Miao et al., 2008).
As previously stated, many factors can inﬂuence cell
fate during LMP-induced apoptosis, including cell type,
the intensity of the cell death stimulus, the state of
cellular transformation, the amount of endogenous
antioxidants and the levels of endogenous cathepsin
inhibitors. In addition, in a given experimental system,
very similar compounds may trigger multiple signaling
pathways that lead to cell death. For example, ultra-
violet C irradiation of HeLa cells treated with two very
similar ﬂuoroquinonole antibiotics, norﬂoxacin and
ciproﬂoxacin, converts cell death from an ROS-depen-
dent, caspase-independent pathway to an ROS-indepen-
dent, caspase-dependent pathway (Boya et al., 2003a).
LMP in cancer cells
Cathepsins are often upregulated in human cancers and
their high levels of expression have been correlated with
an increased risk of relapse and poor prognosis (Gyrd-
Hansen et al., 2004; Palermo and Joyce, 2008).
Cathepsins contribute to distinct tumorigenic processes
such as angiogenesis, metastasis and invasion, and these
functions are attributed to the extracellular actions of
cathepsins once they have been released from secretory
lysosomes (Palermo and Joyce, 2008). Thus, cathepsins
participate in the degradation of basement membranes
and extracellular matrix, thereby facilitating tumor
invasion and metastasis (Tardy et al., 2006). Interest-
ingly, each cathepsin participates in a different process
during tumorigenesis, as revealed by speciﬁc cathepsin
knockout mice (Vasiljeva and Turk, 2008). In addition
to these extracellular effects of cathepsins in matrix
remodeling, intracellular lysosome-dependent degrada-
tion also has an important function in tumorigenesis, as
suggested by the observation that collagen degradation
can be blocked by means of speciﬁc intracellular
cathepsin inhibitors (Sameni et al., 2000). In addition
to these tumor-promoting effects of cathepsins, evidence
is emerging that proteases, and in particular cathepsins,
may have a function as tumor suppressors as well
(Lopez-Otin and Matrisian, 2007).
During cellular transformation, cancer cells undergo
profound changes in their lysosomal compartment,
which affect their size, intracellular localization, cathe-
psin expression and enzymatic activity. Immortalization
and transformation have been shown to increase the
susceptibility of mouse embryonic ﬁbroblasts to lyso-
some-dependent cell death induced by anticancer agents
(Fehrenbacher et al., 2004). This effect is mediated
through CB overexpression and increased cathepsin-
dependent cell death. Lysosomal maturation, size and
activity are tightly regulated by phosphatidylinositol-3
kinase (PI3K) (Mousavi et al., 2003), an enzyme that is
activated in many cancers. Inhibition of PI3K induces
the translocation of CB to the cytosol and may sensitize
endothelial cells to TNF-a-induced apoptosis (Madge
et al., 2003; Li and Pober, 2005). Hsp70 may promote
tumorigenesis by stabilizing lysosomal membranes and
by protecting cells against LMP induced by hypoxia,
non-inﬂammatory cytokines, oxidative stress, irradia-
tion or anticancer drugs (Rohde et al., 2005). The
reasons for the increased susceptibility of cancer cell
lysosomes to LMP are not understood. As one
possibility, relatively large lysosomes, as found in cancer
cells (Glunde et al., 2003), may be more fragile than
normal-sized lysosomes (Ono et al., 2003). Moreover,
cancer cells exhibit higher metabolic rates and an
increased turnover of iron-containing proteins, leading
to the lysosomal accumulation of iron, with consequent
iron-mediated sensitization to ROS-induced LMP
(Eaton and Qian, 2002). Cancer cells often produce
elevated ROS levels, and the associated higher rate of
spontaneous cathepsin release from lysosomes may
facilitate cell death induction (Gyrd-Hansen et al.,
2004). On theoretical grounds, all these factors render
lysosomes from cancer cells particularly susceptible to
the therapeutic induction of LMP. However, this
speculation awaits experimental veriﬁcation.
Recently, parvoviruses have been shown to induce the
death of glioma cells by inducing LMP with consequent
accumulation of CB and CL in the cytosol, while
reducing the intracellular levels of cystatins B and C. In
addition, intracerebral injection of H1-parvovirus in-
duced tumor regression in a rat glioma model, which
was associated with increased CB activity (Di Piazza
et al., 2007). These results provide circumstantial
evidence that LMP may represent a new therapeutic
strategy for the treatment of brain tumors.
Cancer cells often exhibit a reduced expression of
proapoptotic signaling or effector molecules and/or
overexpress antiapoptotic proteins. The discovery of
alternative non-apoptotic cell death pathways might
stimulate the development of novel therapeutic strate-
gies (Fehrenbacher and Jaattela, 2005). In this regard,
new therapeutic approaches to treat cancer through
lysosomal destablization are emerging and several
experimental anticancer agents developed by the NIH
seem to kill cells through p53-independent LMP (Erdal
et al., 2005). Indeed, the lysosomotropic detergent
siramesine has an antitumorigenic effect in vivo in
mouse models of ﬁbrosarcoma and breast cancer when
administered concomitantly with tumor induction
(Ostenfeld et al., 2005).
Photodynamic therapy combines a drug (a photo-
sensitizing agent) with a speciﬁc wavelength of light to
induce the generation of ROS that kill cancer cells
(Buytaert et al., 2007). The subcellular localization of
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the photosensitizer is of special importance, as it
determines the localization of the primary damage.
Many photosensitizers accumulate in mitochondria or
lysosomes. Whereas photosensitizers that accumulate in
mitochondria tend to induce rapid apoptosis, photo-
sensitizers that enrich in lysosomes may induce either
apoptosis or necrosis (Moor, 2000). Photodynamic
therapy with photosensitizers that accumulate inside
lysosomes may induce cell death dependent on LMP
and cathepsins (Buytaert et al., 2007), as has been shown
for ATX-s10 and N-aspartyl chlorin e6 (Caruso et al.,
2004; Ichinose et al., 2006). In addition, antiapoptotic
members of the Bcl-2 family of proteins are often
degraded after photodynamic therapy, making cells
more sensitive to apoptotic cell death (Xue et al.,
2003; Ichinose et al., 2006).
LMP during development and aging or other diseases
The role of LMP-dependent cell death has not been
extensively investigated in mammalian organogenesis.
CD appears to be overexpressed in areas of prominent
cell death during limb development such as in the
interdigital areas (Zuzarte-Luis et al., 2007b). Similar
observations have been reported in heart development
(Zuzarte-Luis et al., 2007a). CD is expressed during
insect metamorphosis in a tissue- and developmental
stage-speciﬁc manner, and CD expression is transcrip-
tionally regulated by the hormone ecdysone. Depletion
of CD by RNAi arrests larval–pupal metamorphosis
and abolishes DNA fragmentation (Gui et al., 2006).
The role of cathepsin during insect development
may be related to the role of autophagy and lysosome
degradation during Drosophila metamorphosis,
where both autophagy and caspases have prominent
functions (Lee et al., 2002). Caspase knockout animals
possess supernumerary neurons and the knockout of
lysosomal proteases can exacerbate cell death in
different tissues and notably in the brain (Boya and de
la Rosa, 2005).
The combined deﬁciency of CB and CL results in
early-onset neurodegeneration in mice that is reminis-
cent of neuronal ceroid lipofuscinoses (a hereditary
neurodegenerative disease in humans), and cathepsin
B//L/ mice exhibit a major degree of cerebral atrophy
(Felbor et al., 2002). This atrophy is due to the
massive apoptosis of selected neurons in the cerebral
cortex and in the cerebellar Purkinje and granule cell
layers. Similarly, central nervous system neurons in
CD/ mice display a new form of lysosome accumula-
tion with a neuropathological phenotype that resembles
neuronal ceroid lipofuscinosis (Koike et al., 2000).
Batten disease manifests as massive neuronal degenera-
tion with the accumulation of undigested material inside
lysosomes. Niemann-Pick type C (NPC) disease is an
autosomal recessive disorder caused by mutations of
NPC1 and NPC2 genes. The progressive neurode-
generation that accompanies NPC is fatal, and an
association has been established between autophagic-
lysosomal dysfunction and cholesterol accumulation in
Npc1/mice. Brain levels of lysosomal CD were
signiﬁcantly higher in Npc1/ than in wild-type mice
(Stahl et al., 2007).
Relatively few in vivo studies have addressed the
relationship between lysosomal membrane destabiliza-
tion and pathogenic cell death. LMP likewise
has a major function in hepatic dysfunctions like
cholestasis, where glycochenodeoxycholate induces cas-
pase activation, LMP, CB translocation and cell death,
whereas CB inactivation attenuates liver injury (Canbay
et al., 2003). Moreover, in a dietary murine model of
non-alcoholic fatty liver disease, either genetic or
pharmacological inactivation of CB protects against
the development of hepatic steatosis, liver injury and
insulin resistance with its associated ‘dysmetabolic
syndrome’ (Feldstein et al., 2004). In animal models of
iron overload, iron-mediated lysosomal instability and
enhanced lipid peroxidation occur (Mak and Weglicki,
1985).
Atherosclerosis is an inﬂammatory disease character-
ized by extensive remodeling of the extracellular matrix
(Liu et al., 2004a). It has recently been reported that
atherosclerotic lesions in both humans and mice are
associated with the expression of several lysosomal
proteases, including cathepsins B, D, L and S, which
may affect plaque development and stability. Oxidized
low-density lipoprotein may favor LMP, inducing the
death of phagocytic cells, as this has been shown
in cultured cells (Li and Yuan, 2004; Liu et al., 2004a).
In vivo knockout studies revealed that the deﬁciency
of cathepsin K or S attenuates atherosclerosis (Sukhova
et al., 2003). Another pathogenic situation in which
macrophages have been implicated is lung damage
induced by silica exposure. Silica particles enter cells
by phagocytosis and their reactive surface may interact
with phagolysosomal membranes, thus triggering the
translocation of lysosomal enzymes to the cytosol and
consequent cell death (Thibodeau et al., 2004).
Conclusion
A plethora of cell death-relevant molecules can operate
upstream or downstream of LMP. Although the number
of papers dealing with LMP is ﬁnite, the regulation of
LMP appears rather complex, and the precise sequence
of events that trigger LMP or emanate from LMP has
not been established. In an apparently confusing
fashion, it appears that multiple molecular players can
act both upstream and downstream of LMP. This has
been reported for caspases, ROS, Bax and Bid.
Depending on the stimulus, the cell type and the
transformation status, cells may use the same elements
to ﬁne-tune lethal signaling. In addition, the same
building blocks can control cell death pathways at many
different levels, thus further increasing the perplexing
complexity of lethal signal transduction cascades.
The exact molecular mechanisms that mediate LMP
remain enigmatic. Bcl-2 family members may have
similar permeabilizing properties for lysosomal mem-
branes as they have for mitochondrial membranes, but
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this has not yet been demonstrated in a convincing
fashion in cell-free systems. In this regard, it appears
intriguing that apolipoprotein L is structurally and
functionally similar to proteins of the Bcl-2 family,
insofar that it possesses pore-forming domains and
displays the ability to induce apoptosis in several cell
types (Vanhollebeke and Pays, 2006). Using a bioinfor-
matics approach, apolipoprotein L6 has been identiﬁed
as a BH3-only protein, and its MOMP-inducing and
cell-killing activities are both lost upon deletion of the
BH3 domain (Liu et al., 2005). Whether apolipoprotein
can induce LMP-dependent cell death is currently
unknown. In this context, it appears most intriguing
that apolipoprotein L1 is the major serum factor
endowed with the capacity of lysing Trypanosoma cruzi
and that its trypanolytic effect is correlated with its
capacity to form pores in the lysosomal membrane of
Trypanosoma (Perez-Morga et al., 2005). Thus, one of
the major challenges for further investigation remains
the elucidation of LMP in molecular terms.
For theoretical reasons, it will be of utmost impor-
tance to determine which endogenous inhibitors prevent
LMP, both in normal and in cancer cells, and which
mechanisms mediate the suppression of lysosomal
hydrolases in the cytosol, either by inhibiting their
enzymatic activity or by targeting them to autophagic or
proteasomal destruction. Disinhibiting LMP-dependent
death might unleash self-destructive processes in cancer
cells, especially if the cancer cells were ‘addicted’ to such
inhibitors. One example for such endogenous inhibitors
of LMP is HSP70, a class of HSP70 for which thus far
no speciﬁc chemical inhibitors have been developed.
Future investigations will clarify whether antagonists of
HSP70 or other yet-to-be-discovered LMP inducers may
constitute a useful addition to the clinical oncologist’s
armamentarium.
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